Trial · NCT01156480
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | CRP Level | 3 days | C-reactive protein is a non-specific marker of inflammation, noted to be elevated in infants diagnosed with NEC. |
| Primary | CRP Level | 7 days | C-reactive protein (CRP) is a non-specific measure of inflammation, usually elevated in infants diagnosed with NEC |
| Secondary | Gastrointestinal (GI) Failure (Defined as Not Being on Full Enteral Feeds of 120kcal/kg/Day at 36 Weeks Corrected Age) | 36 weeks corrected gestational age | GI failure |
| Secondary | Spontaneous Intestinal Perforation | at 36 weeks corrected gestational age | Whether or not infants had perforation. |
| Secondary | Need for Gastrointestinal Surgery | at 36 weeks corrected gestational age | Whether or not the infants required GI surgery by 36 weeks CGA |
| Secondary | Incidence of Sepsis | at 40 weeks corrected gestational age | Whether or not enrolled subjects had sepsis before 40 weeks CGA |
| Secondary | Time on Parenteral Nutrition | at 40 weeks corrected gestational age | Total time on parenteral nutrition |
| Secondary | Time to Full Enteral Feeds | at 40 weeks corrected gestational age | this will be assessed as the time needed to achieve full enteral feeds following the diagnosis of NEC. On average, it will be assessed at 40 weeks CGA, near the time of discharge, but there is a subset of infants who will not yet have achieved full enteral feeds at that time, so it may need to be assessed later than 40 weeks CGA |
| Secondary | Length of Stay | at 40 weeks corrected gestational age | this will be assessed at the time of discharge, around 40 weeks CGA on average. A subset of infants may be discharged later than 40 weeks corrected gestational age (CGA), however, so these infants will need to have length of stay assessed later than 40 weeks CGA. |
| Secondary | Growth Velocity | at 40 weeks CGA | Growth velocity after NEC diagnosis, in g/kg/day. |
| Secondary | Mortality | at 40 weeks corrected gestational age |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01156480/registered